Related references
Note: Only part of the references are listed.A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer
Bengt Gustavsson et al.
CLINICAL COLORECTAL CANCER (2015)
Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery
Xiaodong She et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2015)
The control of epidermal growth factor grafted on mesoporous silica nanoparticles for targeted delivery
Xiaodong She et al.
JOURNAL OF MATERIALS CHEMISTRY B (2015)
Multifunctional HER2-Antibody Conjugated Polymeric Nanocarrier-Based Drug Delivery System for Multi-Drug-Resistant Breast Cancer Therapy
Raju Vivek et al.
ACS APPLIED MATERIALS & INTERFACES (2014)
The use of hollow mesoporous silica nanospheres to encapsulate bortezomib and improve efficacy for non-small cell lung cancer therapy
Jia Shen et al.
BIOMATERIALS (2014)
Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells
Xinxin Zhang et al.
BIOMATERIALS (2014)
Synthesis of hollow mesoporous silica nanoparticles with tunable shell thickness and pore size using amphiphilic block copolymers as core templates
Xiaojun Zhou et al.
DALTON TRANSACTIONS (2014)
Overcoming Multidrug Resistance in 2D and 3D Culture Models by Controlled Drug Chitosan-Graft Poly(Caprolactone)-Based Nanoparticles
Wei-Bin Shi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Biphenyl-bridged periodic mesoporous organosilicas: Synthesis and in situ charge-transfer properties
Meng Gao et al.
MICROPOROUS AND MESOPOROUS MATERIALS (2014)
Mechanical and hydrothermal stability of mesoporous materials at extreme conditions
Robert A. Mayanovic et al.
MICROPOROUS AND MESOPOROUS MATERIALS (2014)
Chitosan-g-TPGS Nanoparticles for Anticancer Drug Delivery and Overcoming Multidrug Resistance
Yuanyuan Guo et al.
MOLECULAR PHARMACEUTICS (2014)
In vivo delivery of bovine viral diahorrea virus, E2 protein using hollow mesoporous silica nanoparticles
D. Mahony et al.
NANOSCALE (2014)
Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles
Limin Pan et al.
BIOMATERIALS (2013)
The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil
Long-Hao Li et al.
EUROPEAN JOURNAL OF CANCER (2013)
Multifunctional hybrid silica nanoparticles for controlled doxorubicin loading and release with thermal and pH dual response
Xixue Hu et al.
JOURNAL OF MATERIALS CHEMISTRY B (2013)
Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells
Yu Chen et al.
BIOMATERIALS (2012)
Anti-epithelial cell adhesion molecule monoclonal antibody conjugated fluorescent nanoparticle biosensor for sensitive detection of colon cancer cells
Liang Tao et al.
BIOSENSORS & BIOELECTRONICS (2012)
Nanoliposome-mediated FL/TRAIL double-gene therapy for colon cancer: In vitro and in vivo evaluation
Nian-feng Sun et al.
CANCER LETTERS (2012)
Anti-angiogenesis therapy in cancer: Current challenges and future perspectives
Farbod Shojaei
CANCER LETTERS (2012)
Nanotechnology applied to overcome tumor drug resistance
Zibin Gao et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Overcoming Multidrug Resistance with Mesoporous Silica Nanorods as Nanocarrier of Doxorubicin
Linlin Li et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2012)
Ceria-engineered nanomaterial distribution in, and clearance from, blood: size matters
Mo Dan et al.
NANOMEDICINE (2012)
Controlled Intracellular Release of Doxorubicin in Multidrug-Resistant Cancer Cells by Tuning the Shell-Pore Sizes of Mesoporous Silica Nanoparticles
Yu Gao et al.
ACS NANO (2011)
A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance
Qianjun He et al.
BIOMATERIALS (2011)
Chemotherapeutic Evaluation of a Synthetic Tubulysin Analogue-Dendrimer Conjugate in C26 Tumor Bearing Mice
William C. Floyd et al.
CHEMMEDCHEM (2011)
Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer
Eva Kopansky et al.
JOURNAL OF DRUG TARGETING (2011)
Enhanced Chemotherapy of Cancer Using pH-Sensitive Mesoporous Silica Nanoparticles to Antagonize P-Glycoprotein-Mediated Drug Resistance
I-Ping Huang et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies
Tore-Geir Iversen et al.
NANO TODAY (2011)
Luminescence targeting and imaging using a nanoscale generation 3 dendrimer in an in vivo colorectal metastatic rat model
Marco A. Alcala et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Targeted human serum albumin nanoparticles for specific uptake in EGFR-Expressing colon carcinoma cells
Karin Loew et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism
Jianan Shen et al.
NANOSCALE (2011)
Folic Acid-Conjugated Chitosan Nanoparticles Enhanced Protoporphyrin IX Accumulation in Colorectal Cancer Cells
Shu-Jyuan Yang et al.
BIOCONJUGATE CHEMISTRY (2010)
Cetuximab-conjugated magneto-fluorescent silica nanoparticles for in vivo colon cancer targeting and imaging
Young-Seok Cho et al.
CANCER LETTERS (2010)
In Vivo Molecular Imaging of Colorectal Cancer With Confocal Endomicroscopy by Targeting Epidermal Growth Factor Receptor
Martin Goetz et al.
GASTROENTEROLOGY (2010)
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Multiple Drug Resistance Mechanisms in Cancer
Bruce C. Baguley
MOLECULAR BIOTECHNOLOGY (2010)
Biological Assessment of Triazine Dendrimer: Toxicological Profiles, Solution Behavior, Biodistribution, Drug Release and Efficacy in a PEGylated, Paclitaxel Construct
Su-Tang Lo et al.
MOLECULAR PHARMACEUTICS (2010)
Preliminary evaluation of a nanotechnology-based approach for the more effective diagnosis of colon cancers
Niyom Lue et al.
NANOMEDICINE (2010)
The potential of carcinoembryonic antigen, p53, Ki-67 and glutathion Stransferase-pi as clinico-histopathological markers for colorectal cancer
Zhenyu He et al.
JOURNAL OF BIOMEDICAL RESEARCH (2010)
Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide
Ashish Garg et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Matrix metalloproteases: Underutilized targets for drug delivery
Deepali G. Vartak et al.
JOURNAL OF DRUG TARGETING (2007)
EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells
Christoph Mamot et al.
JOURNAL OF DRUG TARGETING (2006)
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers
P Went et al.
BRITISH JOURNAL OF CANCER (2006)
Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives
JP Spano et al.
ANNALS OF ONCOLOGY (2005)
Cytotoxicity of anticancer drugs incorporated nanoparticles on HT-29 colorectal cancer in solid lipid cell line
L Serpe et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
Four decades of continuing innovation with fluorouracil: Current and future approaches to fluorouracil chemoradiation therapy
TA Rich et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
The human ATP-binding cassette (ABC) transporter superfamily
M Dean et al.
GENOME RESEARCH (2001)
A new property of MCM-41:: Drug delivery system
M Vallet-Regi et al.
CHEMISTRY OF MATERIALS (2001)
Share Paper
